ANDREA DURDEN: Open Payments
NPI 1952078024 · TIFTON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,134 in 116 payments from 12 companies in 2025. Trend: 2023 $229 · 2024 $659 · 2025 $2,134
Food & beverage: $2,085Education: $49
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $540 |
| Madrigal Pharmaceuticals | 17 | $460 |
| Janssen Biotech, Inc. | 19 | $348 |
| Aimmune Therapeutics, Inc. | 22 | $276 |
| Ardelyx, Inc. | 11 | $228 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 10 | $152 |
| QOL Medical, LLC | 1 | $43 |
| Celltrion USA Inc. | 1 | $26 |
| IRONWOOD PHARMACEUTICALS, INC | 1 | $21 |
| Phathom Pharmaceuticals, Inc. | 2 | $15 |
Products named: REZDIFFRA, TREMFYA, RINVOQ, ZENPEP, IBSRELA, SKYRIZI, XIFAXAN, LINZESS.
Industry payments across GA — which companies pay providers there.
